Table 2. Treatment and treatment outcomes for patients with extensively drug-resistant tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa, 2006–2010*.
| Characteristic | Total, n = 355 | HIV negative, n = 124 | HIV positive, receiving ARVs, n = 114 | HIV positive, not receiving ARVs, n = 79 | HIV positive, ARV status unknown, n = 27 | p value† |
|---|---|---|---|---|---|---|
| No. drugs in treatment regimen | 5 (5–6) | 5 (5) | 5 (5–6) | 5 (5) | 5 (5–6) | 0.56 |
| Effective drug treatment | 109 (31.7) | 29 (26.6) | 46 (42.2) | 32 (29.4) | 2 (1.8) | 0.0004 |
| Any culture conversion | 77 (22.4) | 28 (22.6) | 33 (29.0) | 12 (15.2) | 4 (14.8) | 0.11 |
| Alive after 2 y treatment | 96 (27.9) | 46 (37.1) | 30 (26.3) | 18 (22.8) | 2 (7.4) | 0.007 |
| Favorable treatment outcome | 34 (10.3) | 15 (12.3) | 13 (12.2) | 5 (6.6) | 1 (4.0) | 0.37 |
*Values are median (interquartile range) or no. (%). p values in bold are statistically significant. ARVs, antiretroviral drugs. †Calculation excluded 11 patients with unknown HIV status.